Treatment of full-thickness macular holes with autologous serum

Japanese Journal of Ophthalmology

Volumn 41, Issue 5, 1997, Pages 332-338

  Kusaka, Shunji ^a,b   Sakagami, Kenji ^c   Kutsuna, Miki ^c   Ohashi, Yuichi ^c  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c NONE

Author keywords

Autologous serum; Macular hole; Retinal perforations; Treatments; Vitrectomy

Indexed keywords

OCTAFLUOROPROPANE;

ADULT; AGE; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETINA MACULA HOLE; RETINA TEAR; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD; CATARACT EXTRACTION; FEMALE; FLUOROCARBONS; HUMANS; MALE; MIDDLE AGED; RETINAL PERFORATIONS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 0030697918     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(97)00055-5     Document Type: Article

References (21)

1. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: Results of pilot study. Arch Ophthalmol 1991;109:654-9.
2. Makino S, Inoda S, Shimizu Y, Shimizu H. Results of vitreous surgery for idiopathic macular holes and retinal sensitivity. Nippon Ganka Gakkai Zasshi 1995;99:829-33.
3. Motokura M, Emi K, Shiotani Y, Gomi F, Imai T, Soma N. Significance of epiretinal membrane removal during vitrectomy for idiopathic macular holes. Rinsho Ganka 1994;48:1707-11.
4. Ogino N. Results of macular hole surgery. Nippon Ganka Gakkai Zasshi 1995;99:938-44.
5. Tsujikawa A, Ogura Y, Honda Y. Surgical results of vitrectomy for idiopathic macular hole: Factors affecting postoperative visual prognosis. Nippon Ganka Gakkai Zasshi 1995; 99:450-4.
6. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671-6.
7. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefe's Arch Clin Exp Ophthalmol 1995; 233:549-54.
8. Maeno T, Hattori T, Ninomiya Y, et al. Visual function changes in idiopathic macular holes treated by vitrectomy. Nippon Ganka Gakkai Zasshi 1996;100:40-5.
9. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA. Transforming growth factor-β2 for the treatment of full-thickness macular holes: A prospective randomized study. Ophthalmology 1992;99:1162-73.
10. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-β2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Retina 1993;13:296-301.
11. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effect of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology 1994;101:1195-200.
12. Liggett PE, Skolik DSA, Horio B, Saito Y, Alfaro V, Mieler W. Human autologous serum for the treatment of full-thickness macular holes: A preliminary study. Ophthalmology 1995;102:1071-6.
13. Miyamura M, Tanaka T, Ohtani A, et al. Vitreous surgery with autologous serum for full-thickness macular holes. Rinsho Ganka 1995;1679-82.
14. Mori K, Yoneya S, Abe T. Vitrectomy with autoserum for idiopathic macular hole. Nippon Ganka Gakkai Zasshi 1996; 100:458-63.
15. Johnson RN, Gass JDM. Idiopathic senile macular hole: Observations, stages of formation, and implications for surgical intervention. Ophthalmology 1988;95:917-24.
16. Tano Y. Micro-hooked needle. Ganka Shujutsu 1988;1:313-5.
17. Funata M, Wendel RT, de la Cruz Z, Green WR. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina 1992;12:289-98.
18. Madreperla SA, Geiger GL, Funata M, de la Cruz Z , Green WR. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology 1995;101:682-6.
19. de Jaun E, Dickson JS, Hjelmeland L. Serum is chemotactic for retinal-derived glial cells. Arch Ophthalmol 1988;106:986-90.
20. Campociaro PA, Jerdan JA, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol 1992;102:1830-3.
21. Christmas NJ, Skolik SA,Howard MA, Saito Y, Barnstable CJ, Liggett PE. Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology 1995;102: 263-71.